✦ LIBER ✦

Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab

✍ Scribed by Bruce E. Sands; Richard Kozarek; Jack Spainhour; Charles F. Barish; Scott Becker; Lawrence Goldberg; Seymour Katz; Ronald Goldblum; Rena Harrigan; Deborah Hilton; Stephen B. Hanauer

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 326 KB
Volume: 13
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.20014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and tolerability of concurrent na

Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab

✍ Bruce E. Sands; Richard Kozarek; Jack Spainhour; Charles F. Barish; Scott Becker 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB 👁 2 views

## Background: Natalizumab, a humanized monoclonal igg(4) antibody to alpha4 integrin, was investigated as a treatment of active crohn's disease (cd). the safety of natalizumab given in combination with infliximab has not previously been studied. ## Methods: Seventy-nine adult patients with activ

Safety and effectiveness of long-term bu

Safety and effectiveness of long-term budesonide treatment in maintaining remission in patients with mild-to-moderate Crohn's disease

✍ Antonio Tursi; Gian Marco Giorgetti; Giovanni Brandimarte; Walter Elisei 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 2 views